Research Agreement Signed Between the Vice Presidency for Science, Technology and Knowledge-Based Economy and Khatam University

According to the Public Relations and Website Office of Khatam University, as part of the university’s expanding research collaborations with national institutions and to develop innovative technologies in the healthcare sector, a research agreement entitled “Development of Technology Related to an Ultrasonic Mucus-Removal Device to Improve Respiratory Function in Patients with Cystic Fibrosis” has been signed between the Vice Presidency for Science, Technology and Knowledge-Based Economy and Khatam University.

The scientific responsibility for implementing the project has been assigned to Dr. Masoumeh Azadegan, a faculty member of the Department of Electrical Engineering at Khatam University. The project will draw on the university’s scientific and research capacities and aims to develop technological solutions to help improve the respiratory condition of patients with cystic fibrosis.

Cystic fibrosis is a chronic genetic disease that affects patients’ quality of life by disrupting respiratory function. The accumulation of thick secretions in the airways is one of the most significant consequences of the disease, and managing these secretions is critical to maintaining patient health and improving lung function. In this context, the use of ultrasonic technology could pave the way for the development of innovative medical devices that help facilitate airway clearance and increase the effectiveness of treatment processes.

This research agreement, concluded under the supervision of Khatam University’s Research Affairs Department, represents a valuable step toward developing problem-oriented research, commercializing scientific achievements, and strengthening the university’s engagement with institutions that support technology and innovation in the country. It is hoped that the results of this project will not only advance technical knowledge in the field of advanced medical equipment, but also help improve the quality of healthcare services and the living conditions of patients with cystic fibrosis.